APAC / Medtech's Post-COVID Paradigm
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…
written on 01.03.2011
MEA / Pfizer’s Saudi Transformation; Urgent Call for Arab Import Reform; Hikma & Tabuk Deals
The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…
USA / NORD COO on Health Equity's Vital Importance for Rare Disease Patients
With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…